TRXC TransEnterix Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TRXC TransEnterix

TRXC 0.348

+0.6%

Aug 21 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Savant	1/27/2016 8:01:55 PM
	of 13

At TransEnterix, we believe that advancements in robotic surgery must build on the success of laparoscopy and address the limitations of current robotic systems, while providing a compelling economic value. The company is in the final phases of development and commercialization of the SurgiBot™ System, a minimally invasive surgical platform that is designed to deliver high quality visualization, instrument dexterity and precision, surgeon comfort, and patient cosmesis. The system utilizes flexible instruments controlled directly by the surgeon from inside the sterile field, with robotic assistance. The system allows multiple instruments to be introduced and deployed through a single incision transenterix.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next